BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guarino MPL, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol 2013; 19(31): 5029-5034 [PMID: 23964136 DOI: 10.3748/wjg.v19.i31.5029] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Alhumaidha KA, El-awdan SA, El-iraky WI, El-denshary ES. Protective effects of ursodeoxycholic acid on ceftriaxone-induced hepatic injury in rats. Bulletin of Faculty of Pharmacy, Cairo University 2014;52:45-50. [DOI: 10.1016/j.bfopcu.2014.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ratti E, Berry JD, Greenblatt DJ, Loci L, Ellrodt AS, Shefner JM, Cudkowicz ME. Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone. Toxicol Rep 2015;2:1396-403. [PMID: 26705515 DOI: 10.1016/j.toxrep.2015.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gertzen CGW, Gohlke H, Häussinger D, Herebian D, Keitel V, Kubitz R, Mayatepek E, Schmitt L. The many facets of bile acids in the physiology and pathophysiology of the human liver. Biol Chem 2021;402:1047-62. [PMID: 34049433 DOI: 10.1515/hsz-2021-0156] [Reference Citation Analysis]
4 Littlefield A, Lenahan C. Cholelithiasis: Presentation and Management. J Midwifery Womens Health 2019;64:289-97. [PMID: 30908805 DOI: 10.1111/jmwh.12959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Song J, Chen J, Lin C. Therapeutic Effect of Laparoscopic Cholecystectomy on Patients with Cholecystolithiasis Complicated with Chronic Cholecystitis and Postoperative Quality of Life. Evid Based Complement Alternat Med 2022;2022:6813756. [PMID: 35911139 DOI: 10.1155/2022/6813756] [Reference Citation Analysis]
6 Chen YD, Cai HB, Liu P, Peng Y. Non-surgical treatment of cholesterol gallstones: An update on recent developments. Shijie Huaren Xiaohua Zazhi 2018; 26(25): 1511-1516 [DOI: 10.11569/wcjd.v26.i25.1511] [Reference Citation Analysis]
7 Prencipe N, Bona C, Cuboni D, Parasiliti-Caprino M, Berton AM, Fenoglio LM, Gasco V, Ghigo E, Grottoli S. Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment. Pituitary 2021;24:242-51. [PMID: 33164134 DOI: 10.1007/s11102-020-01102-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sakran N, Dar R, Assalia A, Neeman Z, Farraj M, Sherf-Dagan S, Gralnek IM, Hazzan R, Mokary SE, Nevo-Aboody H, Dola T, Kaplan U, Hershko D. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial. Updates Surg 2020;72:1125-33. [PMID: 32666477 DOI: 10.1007/s13304-020-00850-2] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sci 2021;271:119220. [PMID: 33592199 DOI: 10.1016/j.lfs.2021.119220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Weng SC, Lee HC, Yeung CY, Chan WT, Liu HC, Jiang CB. Choledochal cyst as an important risk factor for pediatric gallstones in low-incidence populations: A single-center review. Pediatr Neonatol 2020;61:598-605. [PMID: 32773363 DOI: 10.1016/j.pedneo.2020.07.013] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yoo KS. [Management of Gallstone]. Korean J Gastroenterol 2018;71:253-9. [PMID: 29791983 DOI: 10.4166/kjg.2018.71.5.253] [Reference Citation Analysis]
12 Wu Y, Dong X, Wu R, Zheng X, Jin Y, Yang H. Efficacy and safety of spleen aminopeptide oral lyophilized powder in ameliorating liver injury in infants and children with human cytomegalovirus infection: a single-center study in China. Transl Pediatr 2021;10:136-45. [PMID: 33633945 DOI: 10.21037/tp-20-173] [Reference Citation Analysis]
13 Faraoni EY, Ju C, Robson SC, Eltzschig HK, Bailey-lundberg JM. Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases. Front Physiol 2022;13:849258. [DOI: 10.3389/fphys.2022.849258] [Reference Citation Analysis]
14 Dubnov-Raz G, Inge TH, Ben-Ami M, Pienik R, Vusiker I, Yardeni D. Body composition changes in adolescents after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2016;12:322-9. [PMID: 26525372 DOI: 10.1016/j.soard.2015.07.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Oh JK, Kim YR, Lee B, Choi YM, Kim SH. Prevention of Cholesterol Gallstone Formation by Lactobacillus acidophilus ATCC 43121 and Lactobacillus fermentum MF27 in Lithogenic Diet-Induced Mice. Food Sci Anim Resour 2021;41:343-52. [PMID: 33987554 DOI: 10.5851/kosfa.2020.e93] [Reference Citation Analysis]
16 Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 2016;7:22-39. [PMID: 26939849 DOI: 10.1080/19490976.2015.1127483] [Cited by in Crossref: 447] [Cited by in F6Publishing: 373] [Article Influence: 74.5] [Reference Citation Analysis]
17 Farashbandi AL, Shariati M, Mokhtari M. Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver. Ethiop J Health Sci 2021;31:673-82. [PMID: 34483625 DOI: 10.4314/ejhs.v31i3.25] [Reference Citation Analysis]
18 Tuna Kirsaclioglu C, Çuhacı Çakır B, Bayram G, Akbıyık F, Işık P, Tunç B. Risk factors, complications and outcome of cholelithiasis in children: A retrospective, single-centre review. J Paediatr Child Health 2016;52:944-9. [PMID: 27236017 DOI: 10.1111/jpc.13235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
19 Castro-torres IG, De la O-arciniega M, Bravo-duarte GA, Gallegos-estudillo J, Domínguez-ortíz MÁ, Martínez-vázquez M. Intestinal and hepatic Niemann–Pick C1L1 proteins: Future therapeutic targets for cholesterol gallstones disease? European Journal of Pharmacology 2014;728:77-81. [DOI: 10.1016/j.ejphar.2014.01.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Juřica J, Dovrtělová G, Nosková K, Zendulka O. Bile Acids, Nuclear Receptors and Cytochrome P450. Physiol Res. [DOI: 10.33549/physiolres.933512] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
21 Lickteig AJ, Csanaky IL, Pratt-Hyatt M, Klaassen CD. Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver. Toxicol Sci 2016;151:403-18. [PMID: 26984780 DOI: 10.1093/toxsci/kfw054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
22 Fukuba N, Ishihara S, Sonoyama H, Yamashita N, Aimi M, Mishima Y, Mishiro T, Tobita H, Shibagaki K, Oshima N, Moriyama I, Kawashima K, Miyake T, Ishimura N, Sato S, Kinoshita Y. Proton pump inhibitor is a risk factor for recurrence of common bile duct stones after endoscopic sphincterotomy - propensity score matching analysis. Endosc Int Open 2017;5:E291-6. [PMID: 28382327 DOI: 10.1055/s-0043-102936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Castro-torres IG, Cárdenas-vázquez RDJ, Velázquez-gonzález C, Ventura-martínez R, De la O-arciniega M, Naranjo-rodríguez EB, Martínez-vázquez M. Future therapeutic targets for the treatment and prevention of cholesterol gallstones. European Journal of Pharmacology 2015;765:366-74. [DOI: 10.1016/j.ejphar.2015.08.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Dikman E, Soldatov A, Chirev A. The study of the possibility of drug dissolution of gallbladder calculi. SR 2020;40:363-6. [DOI: 10.1108/sr-12-2019-0301] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Uyeda JW, Richardson IJ, Sodickson AD. Making the invisible visible: improving conspicuity of noncalcified gallstones using dual-energy CT. Abdom Radiol (NY) 2017;42:2933-9. [PMID: 28660332 DOI: 10.1007/s00261-017-1229-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]